BRS5-FM3-PM8 - Neurotransmitter Precursor Biotransformation & Availability
(Gut Processing of Mood-Related Amino Acids)
1. Mission & Overview
Mission
Maintain gut-side processing that shapes neurotransmitter precursor availability.
Overview
Tryptophan and tyrosine are amino acid precursors used to make serotonin and dopamine-related signalling molecules in the brain. Gut microbes and absorptive processes influence how much of these precursors remain available for central use rather than being diverted or metabolised in the gut. Protein quality, fibre intake and barrier integrity all influence this gut-side precursor context.
- Influences microbial and absorptive handling of tryptophan and tyrosine precursors.
- Shapes gut-side availability relevant to central neurotransmitter biology.
- Highlights adequate protein, B vitamins and fermentable fibre as supporting dietary inputs.
2. Primary Biological Effects
↑ tryptophan/tyrosine availability for central synthesis
3. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework. Biology → Phenome Confidence reflects how directly this mechanism's biology would be expected to affect the phenome within BRAIN architecture — not dietary treatment efficacy. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Rationale: ADHD microbiota compositional differences and lower SCFA levels imply altered microbial biotransformation of dietary precursors relevant to gut–brain neurotransmitter availability — mechanism boundary is microbial precursor processing, not BRS1 monoamine synthesis.
- Key References:
- Evidence Confidence: Low
- Biology → Phenome Confidence: Low
- Rationale: Microbial metabolite handling intersects reward-anticipation biology linked to gut composition in ADHD — indirect motivation framing through precursor/metabolite availability rather than direct drive-outcome trials.
- Key References:
- Evidence Confidence: Low
4. Levers
Intervention Profile
Intervention Dominance: Diet-Supported
- Protein-rich whole foods ← precursor supply context
- Fibre/polyphenol-rich pattern ← absorptive and ecological support
- Lower-dysbiosis pattern ← improved precursor-handling environment
- Vitamin B6 ← poultry, fish, chickpeas
- iron
- Magnesium ← leafy greens, nuts, seeds
- protein sufficiency
-
Inulin/GOS ← onions, chicory, legumes
-
Pectin/soluble fibre ← oats, apples, flax seeds
-
Resistant starch ← cooled potatoes, cooled rice, green bananas
-
Omega-3 fatty acids ← oily fish, algae, eggs
-
Vitamin A precursors and retinol ← eggs, liver, orange vegetables
-
Zinc ← seafood, meat, legumes, seeds
-
Glutamine-supportive amino-acid pool ← fish, eggs, poultry, legumes
1. Food Preparation & Delivery ONLY
- Repeated dietary pattern quality matters more than isolated amino-acid emphasis.
- Prepare fermentable staples and include traditionally fermented foods where tolerated — see Lentils — Preparation.
- Pair fat-soluble compounds with dietary fat to support absorption — see Sweet Potatoes — Synergies.
- Gentle cooking of marine-fat sources helps limit oxidative degradation of PUFA-rich meal matrices — see Salmon — Preparation, Mackerel — Preparation.
- Sleep, stress, and meal irregularity may indirectly worsen gut-side precursor context.
5. Mechanistic Basis
Summary
BRS5-FM3-PM8 links microbial ecology, barrier integrity, and dietary precursor context to the availability of neurotransmitter-relevant amino acids for downstream BRS1 use [O'Mahony et al., 2015; Sinha et al., 2024].
(Gut influence on precursor availability)
Gut ecology and barrier state can influence precursor metabolism, absorptive context, and the downstream availability of amino acids relevant to central neurotransmitter synthesis.
(Not a replacement for BRS1)
This PM does not move neurotransmitter synthesis into BRS5; it describes how the gut environment can influence the precursor context that BRS1 mechanisms later use.
(Pattern-level support)
Protein-rich whole foods, fibre/polyphenol-supported ecology, and lower dysbiosis burden are more relevant than any single “precursor food” in isolation.
5.1 Evidence Highlights
Introduction/Summary
Gut-side precursor metabolism and absorptive biology is well established. The studies below do not redefine central neurotransmitter synthesis; they highlight tryptophan-metabolism and fibre-directed microbial interaction findings that refine how gut-side precursor context is interpreted for downstream BRS1 use.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Serotonin and tryptophan metabolism intersect microbial ecology, barrier state, and gut–brain signalling — supporting precursor biotransformation as a gut-side modulator of amino-acid handling relevant to central synthesis context [O'Mahony et al., 2015].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Dietary fibre directs microbial tryptophan metabolism through metabolic interactions in the gut — linking fermentable-fibre patterns to which tryptophan metabolites are produced and how much precursor remains available for absorptive uptake [Sinha et al., 2024].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Gut ecology and barrier integrity influence precursor metabolism and absorptive context for neurotransmitter-relevant amino acids such as tryptophan and tyrosine without relocating core synthesis biology from BRS1 [O'Mahony et al., 2015].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Protein-rich whole foods combined with fibre-supported ecology provide more relevant gut-side precursor context than isolated amino-acid emphasis — the pattern logic this PM operationalises [Sinha et al., 2024]; [O'Mahony et al., 2015].
- Key References:
6. BRS Pathways and Connections
6.1 BRS Pathways
- None listed
6.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS1-FM3-PM6 - Neuronal Membrane DHA Incorporation — biological connection relevant to this mechanism
- BRS6-FM1-PM2 - Glycaemic Variability Regulation — biological connection relevant to this mechanism
6.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
7. Scoreable Inputs & Modulation Signals
This PM is scoreable through precursor-support and gut-context signals.
| Input Category | Example Inputs | PM6 Relevance |
|---|---|---|
| Functional Property Potentials | precursor_support; gut_barrier_support; lower_dysbiosis_context | May support precursor biotransformation and availability. |
| Realised Functional States | protein_plus_fibre_pattern; lower_dysbiosis_pattern | Reflect practical gut-side precursor support states. |
| Preparation Transformations | minimally_processed; whole_food_matrix | May preserve precursor and absorptive context. |
8. References
- O'Mahony et al. (2015) — Serotonin, Tryptophan Metabolism and the Brain-gut-microbiome Axis
- Sinha et al. (2024) — Dietary Fibre Directs Microbial Tryptophan Metabolism via Metabolic Interactions in the Gut
- Jiang et al. (2018) — Gut Microbiota Profiles in Treatment-naïve Children with Attention Deficit Hyperactivity Disorder
- Steckler et al. (2024) — Dysbiosis and Decreased Short-chain Fatty Acids
- Aarts et al. (2017) — Gut Microbiome in ADHD and Its Relation to Neural Reward Anticipation